Profil

Hoyos Clotilde

Main Referenced Co-authors
Hamaïdia, Malik  (9)
Willems, Luc  (9)
Duysinx, Bernard  (5)
Louis, Renaud  (5)
Brossel, Hélène  (4)
Main Referenced Keywords
BLV (2); HTLV (2); Leukemia (2); mesothelioma (2); Cancer immunotherapy (1);
Main Referenced Unit & Research Centers
Gembloux Agro-Bio Tech - University of Liège (1)
Main Referenced Disciplines
Oncology (11)
Immunology & infectious disease (7)
Cardiovascular & respiratory systems (1)
Biochemistry, biophysics & molecular biology (1)
Veterinary medicine & animal health (1)

Publications (total 13)

The most downloaded
142 downloads
Hoyos, C. (2022). L’inhibition HDAC induite par le valproate améliore la cytotoxicité directe des monocytes contre les cellules de mésothéliome pleural malin [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/292542 https://hdl.handle.net/2268/292542

The most cited

38 citations (Scopus®)

Hamaïdia, M., Gazon, H., Hoyos, C., Hoffmann, G. B., Louis, R., Duysinx, B., & Willems, L. (2019). Inhibition of EZH2 methyltransferase decreases immunoediting of mesothelioma cells by autologous macrophages through a PD-1-dependent mechanism. JCI Insight, 4 (18), 128474. doi:10.1172/jci.insight.128474 https://hdl.handle.net/2268/241122

Hoyos, C. (2022). L’inhibition HDAC induite par le valproate améliore la cytotoxicité directe des monocytes contre les cellules de mésothéliome pleural malin [Doctoral thesis, ULiège - Université de Liège]. ORBi-University of Liège. https://orbi.uliege.be/handle/2268/292542

Hoyos, C.* , Fontaine, A.* , Jacques, J.-R., Heinen, V., Louis, R., Duysinx, B., Scherpereel, A., Wasielewski, E., Jamakhani, M.* , Hamaïdia, M.* , & Willems, L.*. (2022). HDAC Inhibition with Valproate Improves Direct Cytotoxicity of Monocytes against Mesothelioma Tumor Cells. Cancers, 14 (9), 2164. doi:10.3390/cancers14092164
Peer Reviewed verified by ORBi
* These authors have contributed equally to this work.

Hoyos, C., Fontaine, A., Brossel, H., Willems, M., Jamakhani, M., Vandermeers, F., Safari, R., HEINEN, V., LOUIS, R., DUYSINX, B., Scherpereel, A., Wasielewski, E., Mascaux, C., Hamaïdia, M.* , & Willems, L.*. (14 December 2021). Contribution of lysine deacetylases to the therapy of malignant pleural mesothelioma [Poster presentation]. Giga Cancer Day, Liège, Belgium.
* These authors have contributed equally to this work.

Hoyos, C. (14 December 2021). Contribution of lysine deacetylases to the therapy of malignant pleural mesothelioma [Paper presentation]. Giga Cancer Day, Liège, Belgium.

Willems, M., Jamakhani, M., Scherpereel, A., Wasielewski, E., Brossel, H., Fontaine, A., Hoyos, C., Grégoire, M., Louis, R., Duysinx, B., Hamaïdia, M.* , & Willems, L.*. (14 December 2021). Eosinophils inhibit malignant pleural mesothelioma response to chemotherapy [Poster presentation]. GIGA-Cancer Day, Liège, Belgium.
* These authors have contributed equally to this work.

Hoyos, C. (26 March 2021). The contribution of hdac inhibition in therapy of malignant pleural mesothelioma [Paper presentation]. Séminaire du Giga-Cancer, Liège, Belgium.

Brossel, H., Fontaine, A., Hoyos, C., Jamakhani, M., Willems, M., Hamaïdia, M., & Willems, L. (2021). Activation of DNA Damage Tolerance Pathways May Improve Immunotherapy of Mesothelioma. Cancers, 13, 3211. doi:10.3390/cancers13133211
Peer Reviewed verified by ORBi

Hoyos, C., Hamaïdia, M., Safari, R., & Willems, L. (28 November 2019). Les monocytes possèdent une activité cytotoxique directe envers les cellules de mésothéliome pleural malin [Poster presentation]. 2n des Journées Francophones du Mésothéliome (Nantes), Nantes, France.

Hoyos, C. (19 November 2019). L'inhibition de PD-1 augmente l'activité cytotoxique des macrophages envers les cellules de mésothéliome pleural malin [Paper presentation]. 2e des Journées Francophones du Mésothéliome.

Hamaïdia, M., Gazon, H., Hoyos, C., Hoffmann, G. B., Louis, R., Duysinx, B., & Willems, L. (2019). Inhibition of EZH2 methyltransferase decreases immunoediting of mesothelioma cells by autologous macrophages through a PD-1-dependent mechanism. JCI Insight, 4 (18), 128474. doi:10.1172/jci.insight.128474
Peer Reviewed verified by ORBi

Abdala, A., Alvarez, I., Brossel, H., Calvinho, L., Carignano, H., Franco, L., Gazon, H., Gillissen, C., Hamaïdia, M., Hoyos, C., Jacques, J.-R., Joris, T., Laval, F., Petersen, M., Porquet, F., Porta, N., Ruiz, V., Safari, R., Suárez Archilla, G., ... Willems, L. (2019). BLV: lessons on vaccine development. Retrovirology, 2019 (16), 26. doi:10.1186/s12977-019-0488-8
Peer Reviewed verified by ORBi

Hoyos, C., Hamaïdia, M., Black, I., DUYSINX, B., LOUIS, R., & Willems, L. (28 May 2018). Immunoediting activity of macrophages against mesothelioma cells [Poster presentation]. Séminaire de l'EDT-Immunologie, Liège, Belgium.

Gazon, H., Chauhan, P. S., Hamaïdia, M., Hoyos, C., Li, L., Safari, R., & Willems, L. (2018). How Does HTLV-1 Undergo Oncogene-Dependent Replication Despite a Strong Immune Response? Frontiers in Microbiology, 8, 2684. doi:10.3389/fmicb.2017.02684
Peer Reviewed verified by ORBi

Contact ORBi